Lewis H Romer

Title: Lewis H Romer: Innovator in Cardiovascular Treatment

Introduction

Lewis H Romer is a notable inventor based in Baltimore, MD (US), recognized for his contributions to the field of cardiovascular medicine. He holds 2 patents that focus on innovative treatments for various cardiovascular disorders. His work has significant implications for diagnosing and treating conditions that affect heart health.

Latest Patents

One of Romer's latest patents involves antibodies specific for LOX1 and their use in the treatment of cardiovascular disorders. This patent discloses LOX1 binding proteins, such as anti-LOX1 antibodies, along with compositions and methods for creating these binding proteins. The LOX1-binding proteins provided in this patent are designed to inhibit or antagonize LOX1 activity. Furthermore, the patent outlines methods for diagnosing and treating conditions associated with atherosclerosis, thrombosis, coronary artery disease (CAD), ischemia, myocardial infarction, acute coronary syndrome (ACS), stroke, reperfusion injury, restenosis, peripheral vascular disease, hypertension, heart failure, chronic inflammation, angiogenesis, preeclampsia, cancer, and other LOX1-mediated diseases and conditions.

Career Highlights

Lewis H Romer is currently associated with Medimmune Limited, where he continues to advance his research and innovations in the medical field. His work has been instrumental in developing therapies that target critical health issues related to cardiovascular diseases.

Collaborations

Romer has collaborated with notable colleagues, including Andrew Grier Buchanan and Matthieu Chodorge, to further enhance the impact of his research and innovations.

Conclusion

Lewis H Romer is a distinguished inventor whose work in developing LOX1-specific antibodies has the potential to transform the treatment of cardiovascular disorders. His contributions to medical science are invaluable and continue to pave the way for future innovations in healthcare.